Latest filing published 07 Mar 2018 for PFIZER INC, €9,173.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Charles H. Hill: trading record in brief
Charles H. Hill is a declared insider at 2 companies; the most frequent names are Pfizer Inc and Zoetis Inc. Over a trading history stretching from 23 February 2011 to 6 March 2018, the count stands at 81 filings.
Market trades split into 1 purchase (€96k) and 22 sales (€8.4M). Sales outweigh purchases by €8.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 42 share grants and 11 option exercises. 2018 to date brings no purchases and 9 sales.
The record was last updated on 7 March 2018 with an open-market sale (€14k) in Pfizer Inc. The last insider purchase was made public on 8 February 2013, 5,021 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Charles H. Hill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 316 shares@ US$35.810.1% of flowCommon StockSEC:0001225208-18-005645:0
- 330 shares@ US$35.800.1% of flowCommon StockSEC:0001225208-18-005645:1
- 493 shares@ US$35.790.1% of flowCommon StockSEC:0001225208-18-005645:2
- 10,715 shares@ US$35.701.8% of flowCommon StockSEC:0001225208-18-005645:3
- 30,539 shares@ US$35.785.2% of flowCommon StockSEC:0001225208-18-005645:4
- 101,872 shares@ US$27.3713.4% of flowCommon StockSEC:0001225208-18-005098:0
- 1,100 shares@ US$36.840.2% of flowCommon StockSEC:0001225208-18-005098:1
- 3,200 shares@ US$36.850.6% of flowCommon StockSEC:0001225208-18-005098:2
- 5,400 shares@ US$36.821.0% of flowCommon StockSEC:0001225208-18-005098:3
- 17,079 shares@ US$36.833.0% of flowCommon StockSEC:0001225208-18-005098:4
- 19,606 shares@ US$36.313.4% of flowCommon StockSEC:0001225208-18-005098:5
- 61,836 shares@ US$35.7010.6% of flowCommon StockSEC:0001225208-18-005098:6
- 43,042 shares0Common StockSEC:0001225208-18-004661:0
- 21,078 shares@ US$37.093.7% of flowCommon StockSEC:0001225208-18-004661:1
- 65,280 shares@ US$18.905.9% of flowCommon StockSEC:0001225208-18-004461:0
- 17,674 shares@ US$36.263.1% of flowCommon StockSEC:0001225208-18-004461:1
- 20,829 shares@ US$35.983.6% of flowCommon StockSEC:0001225208-18-004461:2
- 36,000 shares@ US$34.076.8% of flowCommon StockSEC:0001225208-17-006071:0
- 8,319 shares@ US$34.281.6% of flowCommon StockSEC:0001225208-17-005103:1
- 8,621 shares@ US$34.281.6% of flowCommon StockSEC:0001225208-17-005103:2
- 16,716 shares0Common StockSEC:0001225208-17-005103:0
- 22,837 shares@ US$34.064.3% of flowCommon StockSEC:0001225208-17-004773:0
- 53,918 shares@ US$21.036.0% of flowCommon StockSEC:0001225208-16-041272:0
- 1,300 shares@ US$33.830.2% of flowCommon StockSEC:0001225208-16-033154:0
- 28,300 shares@ US$33.844.9% of flowCommon StockSEC:0001225208-16-033154:1
25 of 81 declarations
